Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis. . Br J Dermatol 2024;191:e3.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis. Br J Dermatol 2024;191:e3.
PMID: 38900670